Hybrid bioartificial liver in hepatic failure: preliminary clinical report

A hybrid bioartificial liver has been developed on the principle of hemodialysis against a suspension of functioning hepatocytes. The new chimeric device of synthetics and living parts was used successfully to treat a patient in hepatic failure due to an inoperable bile duct carcinoma that involved the bifurcation of the common duct.